Michael J. Cuttica MD, Assistant Professor of Medicine at the Northwestern Pulmonary Hypertension Program of Northwestern University discusses Pulmonary Arterial Hypertension in scleroderma patients, including how it is diagnosed and treated.
Michael J. Cuttica MD, Assistant Professor of Medicine at the Northwestern Pulmonary Hypertension Program of Northwestern University discusses Pulmonary Arterial Hypertension in scleroderma patients, including how it is diagnosed and treated.
Rational choice of inotropes and vasopressors in intensive care unitSaneesh P J
The presentation introduces commonly used interpose and vasopressors; their classification; and how to choose the drug in ICU. Clinical scenarios - cariogenic shock; neurocritical care; septic shock and anaphylactic shock are elaborated.
ABGs or VBGs interpretation made simple straight forward easy to remember and easy to apply. The presentation is designed to help the residents and junior ER physicians. The second part will discuss the oxygenation and the third part will review the "Stewart Approach" while fourth and last part is meant for the Experts.
Rational choice of inotropes and vasopressors in intensive care unitSaneesh P J
The presentation introduces commonly used interpose and vasopressors; their classification; and how to choose the drug in ICU. Clinical scenarios - cariogenic shock; neurocritical care; septic shock and anaphylactic shock are elaborated.
ABGs or VBGs interpretation made simple straight forward easy to remember and easy to apply. The presentation is designed to help the residents and junior ER physicians. The second part will discuss the oxygenation and the third part will review the "Stewart Approach" while fourth and last part is meant for the Experts.
CORTICAL SPREADING DEPOLARISATION IN NEUROLOGICAL DISEASE – AN INTRODUCTION
By Toby Jeffcote
Cortical spreading depolarization (CSD) is a spreading loss of ion homeostasis, altered vascular response, change in synaptic architecture, and subsequent depression in electrical activity following an inciting neurological injury.
It was first described by Leão in 1944, a disturbance in neuronal electrophysiology has since been demonstrated in a number of animal studies, and recently a few human studies that examine the occurrence of this depolarizing phenomenon in the setting of a variety of pathological states, including migraines, cerebrovascular accidents, epilepsy, intracranial hemorrhages, and traumatic brain injuries. The onset of CSD has been demonstrated experimentally following a disruption in the neuronal environment leading to glutamate-induced toxicity. This initial event leads to pathological changes in the activity of ion channels that maintain membrane potential. Recovery mechanisms such as sodium-potassium pumps that aim to restore homeostasis fail, leading to osmolar shifts of fluid, swelling of the neuron, and ultimately a measurable depression in cortical activity that spreads in the order of millimeters per minute. Equally important is the resulting change in vascular response. In healthy tissue, increased electrical activity is coupled with release of vasodilatory factors such as nitric oxide and arachidonic acid metabolites that increase local blood flow to meet increased energy expenditure. In damaged tissue, not only is the restorative vascular response lacking but a vasoconstrictive response is promoted and the ischemia that follows adds to the severity of the initial injury. Tissue threatened by this ischemic response is then at elevated risk for CSD propagation and falls into a vicious cycle of electrical and hemodynamic disturbance. Efforts have been made to halt this spreading cortical depression using N-methyl-D-aspartate receptor antagonists and other ion channel blockers to minimize the damaging effects of CSD that can persist long after the triggering insult.
Celia Bradford takes us through the latest on the management of subdural haemorrhage (SDH). She covers acute SDH, chronic SDH and middle meningeal artery embolisation, a novel treatment for chronic SDH management in certain circumstances.
Andy Neill - More neuroanatomy pearls for neurocritical careSMACC Conference
Andy Neill shares some more neuroanatomy wisdom that's highly practical for anyone working with neuro emergencies. This time he covers brain herniation syndromes, hydrocephalus, extradural vs subdural haematomas, cervical spinal imaging, vertebral artery dissection and "things you read on CT reports but don't know what they mean"!
Andrew Udy talks about Brain Tissue Oxygen Monitoring:
It’s Not What You’ve Got It’s What You Do With It
The BONANZA Trial
Andrew Udy talks about the ongoing BONANZA Trial which is assessing whether an algorithm that incorporates both ICP and brain tissue oxygen (PbTO2) can improve outcomes after traumatic brain injury (TBI). Like with all monitoring, how the PbTO2 is interpreted and managed is critical and the devil is in the detail!
More on BONANZA here
More on BOOST3 here
R. Loch Macdonald, M.D., Ph.D.
Community Neurosciences Institute
Fresno, California, USA
Angiographic vasospasm and more accurately, delayed cerebral ischemia, continue to contribute to morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (SAH). It is known that angiographic vasospasm is common after SAH, occurring in two-thirds of patients. Cerebral infarctions that developed days after the SAH have been attributed to angiographic vasospasm, occuring in about a third of patients, although this has always been controversial. Angiographic vasospasm theoretically can only damage the brain by restricting blood flow but there is no easy, accurate, widely available method to measure cerebral blood flow and this is not the measurement we need. Blood flow depends on metabolic demand so what we need to know to determine if angiographic vasospasm is causing ischemia is oxygen extraction fraction in the brain tissue supplied the the spastic artery. Without this measurement, the attribution of ischemia to vasospasm is subjective. Since angiographic vasospasm is essentially the only detectable delayed phenomenon after SAH, we focus on it and apply tremendous resources to preventing or reversing the vasospasm. Undoubtedly angiographic vasospasm can cause cerebral infarctions, but it has to be severe and flow limiting. But SAH is a complex disease. There are many other causes for cerebral infarctions after SAH, the most common being due to the aneurysm repair procedure. And a given degree of vasospasm may cause infarction in a volume-depleted patient with poor collateral blood supply but not in a patient without these things. There also are hypodense brain lesions after SAH that are due to intracerebral hemorrhages. There can be hypodensities in the brain directly under usually thick SAH where the brain dies. This observation in particular supports a role for cortical spreading depolarizations/ischemia as a cause of infarction after SAH. Other macromolecular processes that are hypothesized to cause brain damage after SAH include microthromboembolism, changes in the microcirculation, delayed brain cell apoptosis and capillary transit time heterogeneity. Determining the importance of these things is hindered by the lack of an easy way to detect them in patients. It is also known that poor grade patients, who presumably have more early brain injury and ischemia than good grade patients, are more prone to delayed cerebral ischemia, suggesting increased sensitivity to secondary insults of the already injured brain. We also assume delayed neurological deterioration when attributed to vasospasm or delayed cerebral ischemia, is purely due to ischemia. While knowledge about what happens pathophysiologically after SAH is increasing, management of delayed cerebral ischemia still focuses on detecting angiographic vasospasm and then augmenting the blood pressure to improve cerebral blood flow or dilating the spastic arteries with balloons or drugs.
By Catherine Bell and Andrew Udy
Catherine Bell takes us through how to troubleshoot problems commonly encountered when looking after patients who have an external ventricular drain (EVD) in situ. Issues with using brain tissue oxygen monitors are also discussed. A highly practical session aimed at bedside clinicians.
There is no such thing as mild, moderate and severe TBI - by Andrew UdySMACC Conference
Part 2 of a debate over the classification of TBI. Andrew Udy then argues that this classification is fundamentally flawed. He discusses the issues with the Glasgow Coma Scale, and therefore the follow-on issues in TBI classification, including all the confounders to the GCS, the issues with timing of the score as well as GCS not taking baseline function or specifics subtypes of TBI into account. He makes teh argument that biomarkers may better categorise the diffuse entity we call TBI.
TBI Debate - Mild, moderate and severe categories workSMACC Conference
Andrew Chow, Intensivist with a neurosurgical background, argues that the current categorisation system for traumatic brain injury (TBI) works, and makes sense! He tackles us through the history of this system, and why it’s important to differentiate different types of TBI. The arguments in favour of this categorisation include the consistency and benefits of a universal language, the implications for triage and management, and the fact that this system has been endorsed by all major organisations
Dr Nick Little is an experienced Neurosurgeon who's looked after patients with traumatic brain injury for his whole career. Here he discusses the difficulties of prognostication following traumatic brain injury (TBI). He talks about the statistics of outcomes following mild, moderate and severe TBI and then goes on to tackle the harder topic of how we try to work out what an individual would want if they knew the spectrum of outcomes that they may face. The issues with the clinical examination findings we use to prognosticate are covered, as well as which imaging findings he finds most helpful. He also mentions the difficulties with current prognostic calculators.
Historically, when it came to brain injury, ketamine had a bad rap. Much of that dogma was dispelled in the last decade, and ketamine is now frequently used as an induction agent in acute brain injury, especially traumatic brain injury, due to it’s favorable effects on haemodynamics.
However a new application of ketamine is now being explored - whether ketamine may be able to reduce secondary brain injury.
Managing Complications of Chronic SCI by Bonne LeeSMACC Conference
20 million people around the world are living with a spinal cord injury (SCI). The medical issues they develop over the years differ to any other patient cohort.
These complications include autonomic dysreflexia, management of pressure areas, specific infections, nuanced peri-operative care and highly specific issues such as baclofen pump management and syringomyelia
Do look at the NeuroResus section on this and listen to Spinal Rehab Specialist Bonne Lee talk about this side of SCI care.
Keywords
SCI, spinal, spinal cord injury, autonomic dysreflexia, pressure areas, infection, peri-operative care, baclofen pump, syringomyelia, chronic SCI, spinal trauma, spinal rehab, incomplete SCI
Tania is a neurologist and epileptologist with expertise in continuous EEG (cEEG) and status epilepticus (SE). This talk covers what a seizure is, what status is, including focal and generalised status epilepticus.
So why do we do cEEGs for patients with suspected SE?
To confirm the diagnosis
To see if patient just post ictal or still seizing
To establish that the clinical and electric seizures have stopped
To see if burst suppression is achieved
To exclude other differential diagnoses
She makes a good argument for why cEEG is such an important tool in managing SE.
In the questions after the talk, the issue of availability of cEEG in the Australian setting was discussed. Limited montage EEGs are discussed including their pros and cons.
Stuart Browne is a Neuro Rehab specialist from Sydney. These slides accompany a talk he gave at the Brian Symposium in 2023. He discusses what "severe disability" really means.
Severe disability is more common than many realise - about 6% of the Australian population.
Stuart discusses how health is more than simply physical recovery and how it is a multidimensional construct. He covers how permanent disability doesn't necessarily equate to a poor quality of life. He also discusses the long timespan of recovery, which is often much longer than appreciated.
He specifically discusses "Locked-in Syndrome" and how the survivors have surprisingly positive self-reported health-related quality of life and well-being.
Stuart also covers how severely disabled people face various forms of discrimination.
Shree Basu is a Paediatirc Intensivist in Sydney. These slides from the Brain Symposium 2023 accompany the talk she gave. She discusses how Paediatric stroke presents, what neuroimaging is required and what interventions are available, including thrombolysis and the role of endovascular thrombectomy.
Hypertensing Spinal Cord Injury - gold standard or wacky?SMACC Conference
After spinal cord injury (SCI), there aren’t many interventions we have available that actually make a difference.
Augmenting blood pressure to increase spinal cord perfusion pressure is an attractive concept that may improve neurological outcomes following SCI. We know that hypotension can make SCI worse. Clinical studies looking at blood pressure augmentation are mostly old, retrospective and flawed in various ways.
Aiming for a MAP of > 85 for 5-7 days is recommended by guidelines but why this pressure and duration are good questions.
Hypertensive therapy is relatively safe and easy to implement but not without risk.
Tessa discusses the pros and cons, how this is managed practically and what the future may hold in this area.
Mark Weedon takes us through the increasingly utilised concept of an optimal cerebral perfusion pressure (CPPopt) for each unique patient. He discusses the background to CPPopt, including intrcranial pressure (ICP), the Monroe Kelly hypothesis, neurovascular coupling, and cerebral autoregulation in health and following brain injury. He shows how intracranial pressure is affected by intracranial compliance and how this affects ICP waveforms. Cerebral perfusion pressure in relation to the Brain Trauma Foundation guidelines is covered including management of elevated ICP (EICP). The currently recommended tiered approach to managing cerebral perfusion pressure and EICP is mentioned citing recent guidelines. He uses a clinical case of a TBI to illustrate how the CPPopt can be ascertained and used to guide therapy, including the easy to perform “MAP Challenge”. Mark also describes the Pressure Reactivity Index (PRx) and how it can be used as a target for therapy. Finally, he covers the exciting results of the preliminary COGiTATE pilot study.
Social Worker Victoria Whitfield and Bereavement councilor Louise Sayers discuss the power of words when health professionals are communicating topics around of death and serious injury with relatives and patients in critical care. They use role plays to bring theories to life.
Sepsis and Antimicrobial Stewardship - Two Sides of the Same CoinSMACC Conference
Appropriate use of antimicrobials is primarily a patient safety issue, and is the key aim of an effective antimicrobial stewardship program. We discuss the challenges in the management of a patient with sepsis, and how decision-making is usually done in the absence of effective diagnostics. Time dependent protocols and the knowledge that undertreatment of a patient with sepsis will lead to poor outcomes will lead to prescribing that may be driven by fear. Antimicrobial resistance is associated with over-use of antimicrobials but is usually not the immediate concern. Antimicrobial stewardship programs should work closely with sepsis teams to ensure that sepsis pathways are implemented across the whole hospital, and that key principles of judicious use are embedded within the clinical pathway.
Being able to prognosticate in the aftermath of a traumatic brain injury (TBI) is important as it assists with counselling patients and families. Moreover, it helps rationally allocate healthcare resources.
However, due to the heterogenous nature of TBI and variable pre brain injury patient factors and post brain injury course, this has proven to be a difficult task.
Large cohort studies have enabled improved accuracy in the prediction of 6 month mortality and unfavourable outcome.
Furthermore, many of the factors that contribute to long-term outcome have also emerged. However, it is not yet possible to use them in prediction algorithms or mathematical models.
There is emerging evidence that pre injury psychosocial and demographic factors may be of more relevance than injury severity. Moreover, that 'outcome' becomes increasingly subjective and complex as the post injury duration increases.
We end with three brief vignettes which highlight the fraught nature of long term outcome prediction.
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Feeding plate for a newborn with Cleft Palate.pptxSatvikaPrasad
A feeding plate is a prosthetic device used for newborns with a cleft palate to assist in feeding and improve nutrition intake. From a prosthodontic perspective, this plate acts as a barrier between the oral and nasal cavities, facilitating effective sucking and swallowing by providing a more normal anatomical structure. It helps to prevent milk from entering the nasal passage, thereby reducing the risk of aspiration and enhancing the infant's ability to feed efficiently. The feeding plate also aids in the development of the oral muscles and can contribute to better growth and weight gain. Its custom fabrication and proper fitting by a prosthodontist are crucial for ensuring comfort and functionality, as well as for minimizing potential complications. Early intervention with a feeding plate can significantly improve the quality of life for both the infant and the parents.
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
10. Approach
1. How is the oxygenation?
2. What is the pH?
3. Is there a respiratory component?
4. Is there a metabolic component?
5. Is there compensation?
11. How is the oxygenation?
Pa02
A-a gradient
P:F ratio
15. What is the pH?
pH = 7.4
pH > 7.4
Alkaemia
pH < 7.4
Acidaemia
16. Is there a respiratory component?
PaCO2 with pH = respiratory acidosis
PaCO2 with pH = respiratory alkalosis
Normal pH + abnormal PaCO2 :
Two opposing primary acid-base disorders
OR
Primary respiratory disturbance + metabolic
compensation
17. Is there a metabolic component?
HCO3 + pH = metabolic alkalosis
HCO3 + pH = metabolic acidosis
What is the anion gap?
What is the delta ratio?
18. Is there compensation?
Acute Chronic
Respiratory
Acidosis
Respiratory
Alkalosis
For every 10mmHg change in CO2
HCO3 ↑1 HCO3 ↑4
HCO3 ↓2 HCO3 ↓5
What is an acid? A substance that dissociates in solution to form hydrogen ions (Arrhenius theory) or a substance that donates a proton (hydrogen ion) (Bronsted-Lowry theory) or a substance that acts as an electron pair acceptor (Lewis theory)
What is a base? A substance that dissociates in solution to form hydroxide ions (Arrhenius theory) or a substance that accepts a proton in solution or substance that acts as electron pair donor (Lewis theory)
What is pH? The negative logarithm to base 10 of the hydrogen ion concentration in solution– measures how acidic or basic a substance is
pH = pK + log Base/Acid
pH = potential hydrogen
pK = negative logarithmic of the dissociation constant – the dissociation constant is a measure of the strength of an acid - ratio of concentration of dissociated form to combined form at equilibrium
When pH = pKa the concentration of the conjugate base and acid are equal
The smaller the pKa the greater the acidity and stability of conjugate base
Why is pH important? Body controls pH very tightly – homeostatic mechanisms
Optimal enzyme activity in cells is dependent on a certain pH (most enzymes function within a narrow range only of pH)
Disrupts cell membranes
Required for protein structure and function can interfere with stability and therefore function of protein may become biologically inactive
Required for hormone production, release and function (we know noradrenaline doesn’t work if significant acidosis)
Required for optimal organ function – cardiac contractions weaker with acidosis, predisposed to arrhythmias, peripheral vasodilatation
Required for synapse function
Buffers: substances which have the ability to minimise changes in pH when an acid or base is added to it .first line – react within seconds, bicarbonate can only buffer metabolic acids not respiratory. Do not eliminate excess acids/base – just minimise changes in pH
Bicarbonate buffer: most important for ECF, buffers metabolic acids, relies on respiratory system, open at both ends
Protein buffer system: important intra-cellularly, Hb important especially for co2 buffering
Phosphate buffer system: has three dissociations with different pKas, important intracellular buffer
Partial pressure – the pressure that the gas would exert if occupied that same volume on its own
ctHb: measures all Hb including oxygenated, deoxygenated, carboxyhaemoglobin, methaemoglobin surrogate of potential 02 carrying capacity NOT effective o2 carrying capacity
HCTc_ mathematically produced haematocrit value – ratio between volume of erythrocytes to the volume of whole blood – HCt is proportional to Hb (true if Hb calculated correctly, no intravascular haemolysis and red cells contain expected amount of Hb)
So2: fraction of effective haemoglobin which is oxygenated (concentration of oxyhaemoglobin/concentration of effective haemoglobin)
F02Hb: fractional oxygenated haemoglobin content - fraction of total Hb which is oxygenated (concentration of oxyhaemoglobin/concentration of total Hb)
FC0Hb: fraction of total haemoglobin present as carboxyhaemoglobin – carbon monoxide has > 200 x the affinity for Hb compared to oxygen and isn’t released as easily decreased o2 carrying capacity and also binds to intracellular cytochromes which impairs aerobic metabolism. Also causes oxidative injury, activates inflammatory cascade and lipid peroxidation
Symptoms: < 10% none (commonly found in smokers, normal 0.5%), 10 – 20% value or no symptoms, 30 – 40% headache, tachycardia, confusion, weakness, nausea, vomiting, 50 – 60%: coma, convulsions, arrhythmias, ECG changes, 70 -80%: circulatory and ventilatory failure, cardiac arrest and death.
Increased absorption if increased CO concentration, decreased barometric pressure, increased activity, increased RR, high metabolic rate or anaemia. Half life decreases with o2.
Sources: fire, stoves, heaters, automobile exhaust, charcoal grills, swimming behind motor boat
Sats probe will have falsely elevated reading as COHb absorbs red light similar to O2Hb and does not absorb near IR light – probe finds it hard to differentiate between the two – normally calculates a ratio between red and infrared light
FHHb: fraction of total haemoglobin present as deoxyhaemoglobin
FMetHb: fraction of total haemoglobin present as methaemoglobin – altered state of Hb where Ferrous ions Fe2+ are oxidised to Ferric state Fe3+ and unable to bind oxygen. Normal < 1.2%.
Causes: congenital (Hb M disease, cytochrome B5 reductase deficiency), acquired (benzene derivatives, chloroquine, dapsone, prilocaine, metoclopramide, nitrites, sulphonamides)
Signs: cyanosis, decreased o2 delivery signs, sats 85 – 90%, chocolate brown blood, normal pao2
3 – 15%: minimal symptoms, 15 – 30%: cyanosis, chocolate brown blood, 30 – 50%: drowsiness, headache, dyspnoea, dizziness, 50 – 70%: seizures, coma, dysrhythmia, tachypnoea, acidosis, ischemia, > 70%: death, severe hypoxia
Management: high flow o2, cease precipitants, methylene blue (electron acceptor to facilitate reduction of MetHb)
cBase(ECF)c: standard base excess - amount of acid or base required to titrate anaemic blood Hb 50g/L back to a normal pH of 7.4, normal pc02 40mmHg and at 37 degrees – estimate of ECF buffering
Good to have an approach – like ECGs system makes it less likely to miss things
O2 Hb dissociation curve: relationship between the partial pressure of oxygen and the oxygen saturation of haemoglobin
Saturated vapor pressure of water at body temp
Normal A-a gradient: alveolar hypoventilation, low inspired oxygen (fio2 < 0.21% or atmospheric pressure < 760mmHg)
Raised A-a gradient: diffusion defect, VQ mismatch, right to left shunt, increased o2 extraction
Gradient varies with age and fio2 (age/4 + 4)
RQ is ratio of co2 produced to oxygen consumed per unit time – glucose has RQ of 1, protein 0.8, fat 0.7
Used as risk stratification and in severity scoring
Ratio of arterial oxygen partial pressure to fractional inspired oxygen
At sea level normal PF ratio is 400 – 500mmHg
Alkalemia/acidemia is excessive base or acid in the blood
Alkalosis/acidosis is the process leading to this state
Ph and HCO3 should move in same direction
Electroneutrality – cations = anions
Most of this anion gap is due to serum proteins – especially albumin (for every 4g/L decrease in albumin there is a 1 decrease in the expected anion gap
Why does this cause decreased HCO3?? Buffering – acid from the anions combines with HCO3 to produce carbonic acid co2 + h20
Ketoacidosis (starvation, diabetes, alcohol), lactic acidosis (D or L lactate), renal failure includes citrate toxicity from dialysis, toxins (toxic alcohols, pyroglutamic acidosis, salicylates, citrate toxicity)
Short bowel syndrome leads to an increased load of undigested carbohydrates (including simple sugars) in the colon. As a result, the amount of organic acid produced exceeds the amount that can be metabolized by healthy individuals. This leads to an accumulation of organic acids, including SCFA and lactate, resulting in a more acidic environment than normal. Interestingly, the lower pH favours the growth of bacteria responsible for producing D- and L-lactate as they are acid-resistant and this leads to a further decrease in the pH thus generating a vicious cycle.
Gaining exogenous chloride, losing bicarb via the kidneys or the GIT
Ureteric diversion, small bowel fistula, excessive chloride, exogenous acid, , diarrhoea, resolving DKA, carbonic anhydrase inhibitors, Addisons (type 4 RTA), RTA, pancreatic fistula (USEDCRAP) or (HARDUP – hyperalimentation, acetazolamide, RTA< diarrhoea, ureteroenteric fistula, pancreaticoduodenal fistula, spironolactone)
Diarrhoea – sodium loss in excess of chloride loss – excess chloride
Fistulas: loss of bicarb rich chloride poor fluid
Can help differentiate between GIT and renal causes of hyperchloremic metabolic acidosis
Provides rough estimate of ammonium excretion (ammonium is positively charged so a rise in its urinary concentration will cause a fall in urinary anion gap). Normally slightly positive.
If there is a negative urinary anion gap it means another cation – namely ammonium is being excreted
If acidosis is due to loss of base via bowel then the kidneys respond appropriately to increase ammonium excretion and cause a net loss of hydrogen from body decreased UAG
If acidosis is due to loss of base via kidney then kidney not able to increase ammonium excretion UAG not increased
Low urinary AG: GI loss of base
No change in urinary AG: renal loss of base
Negative urinary AG: severe diarrhoea
Positive urinary AG: altered urinary acidification
Assumes that each acid molecule is buffered by one HCO3 molecule so there is a net increase in unmeasured anion and a decrease in hco3
This assumes that all buffering is by HCO3 (not true some is intracellular – some by Hb and proteins)
Nil significant a-a gradient, severe high anion gap (31) metabolic acidosis with respiratory compensation, delta ratio 1 – HAGMA
Raised glucose
Likely DKA – check ketones
Nil significant A-a gradient, metabolic acidosis with respiratory compensation, raised anion gap (19) but delta ratio = 0.58 (mixed NAGMA + HAGMA) – don’t stop insulin yet
3 x ABGS with lactate
Seizure, 2. ethylene glycol 3. Asthma with salbutamol toxicity
Due to increased production OR decreased utilisation/clearance
Lactate and pyruvate – ongoing conversion via Cori cycle (glucose -> pyruvate -> lactate in glycolysis dependent tissues such as skeletal muscle, blood cells, bone marrow, renal medulla, hypoxic tissue) (lactate:pyruvate in cells normally 10:1)
Lactate -> pyruvate -> glucose in liver
Lactate – mostly converted to glucose in liver, half metabolised to co2 and water in citric acid cycle. Only liver and kidneys can convert lactate to glucose
Although lactate is freely filtered at the glomerulus, it is almost all reabsorbed and normally <2 % of lactate is removed from the body in urine [3]. The principal route of disposal begins with cytosolic conversion to pyruvate by the enzyme lactate dehydrogenase.
This pyruvate has two principal fates. The first is oxidation to acetyl CoA by the enzyme pyruvate dehydrogenase for ultimate metabolism to carbon dioxide and water via the citric acid cycle and oxidative phosphorylation. The second is conversion to glucose, a process called gluconeogenesis. Oxidation of pyruvate via the citric acid cycle can potentially occur in all cells with mitochondrion, but gluconeogenesis is confined to liver and kidney cortex cells.
For this reason liver and kidneys are the most significant organs for lactate elimination, the liver accounting for disposal of around 60 % of circulating lactate [4] and the kidneys for disposal of 25-30 % [5]. Overall, the body has immense capacity for lactate disposal, which can, if necessary (e.g. following extreme exercise), rise as high as 500 mmol/hour, considerably higher than the basal rate of production
Causes
Increased rate of glycolysis
Due to lack of ATP (ATP produced via oxidative phosphorylation produces a lot more ATP (36 versus 2): so any cause of lack of oxygen
Due to exogenous pro-glycolytic stimulus: salbutamol, adrenaline, catecholamines
Pyruvate dehydrogenase issues
Thiamine deficiency: cofactor in oxidative phosphorylation and coenzyme with PDH to form acetyl coA
Sepsis
Errors of metabolism
Defects of oxidative phosphorylation/Krebs cycle
Cyanide: disables electron transport chain
Paracetamol: inhibits electron transport chain
Salicylate: inhibits enzymes involved in Krebs cycle
Metformin: inhibits pyruvate carboxylase (required to change pyruvate to oxaloacetate), inhibits electron transport chain, relative insulin deficiency
Propofol: electron transport chain
Toxic alcohol: increases NADH which favours production of lactate
NRTI: disrupts oxidative phosphorylation
Inborn errors- Decreased clearance: hepatic/renal dysfunction, decreased gluconeogenesis
Seizure:
Historical features: history, meds
Asthma with salbutamol toxicity
History, meds
Ethylene glycol toxicity
Osmolar gap
Calcium oxalate crystals
Ethylene glycol: lactate electrode relies on use of lactate oxidase which conversts lactate into pyruvate producing hydrogen peroxide which is reduced at cathode. Glycolic acid (product from ethylene glycol) also is substrate for enzyme falsely elevates lactate
Can do lactate gap (lactate serum – lactate ABG)
Also confirmed by raised osmolar gap + calcium oxalate crystals in urine
Other things that can interefere: citrate, ethanol, heparin, paracetamol, salicylate and urea, isoniazid
Raised A-a gradient (170.95), metabolic alkalosis with respiratory compensation
How to investigate?
History (antacids, diuretics, b lactams (act as non reabsorbable anions in renal tubule therefore promote potassium and hydrogen excretion), cystic fibrosis,
Urinary Chloride
< 20 (chloride responsive):
- extra-renal loss: vomiting, sweat
Renal loss: post hypercapnoeac, diuretics (remote use now ceased),
>20: chloride resistant:
- Normal/low BP: diuretics, Barters (defect in thick ascending loop of Henle NaK2CL transporter), Gilteman (defect of sodium chloride co-transporter), hypokalemia, hypomag
HTN: (increased mineralocorticoid or mineralocorticoid like effects)
High serum renin: diuretics, renal artery stenosis, renin secreting tumour, MH
Low serum renin
Low serum aldosterone: cushing, corticosteroid, 17 hydroxylase deficiency, Liddle syndrome, licourice overindulgence
High aldosterone: adrenal adenoma, hyperplasia, aldosterone synthase hyperactivity, primary hyperaldosteronism
Urinary hydrogen ion losses increase when relatively generous sodium and water delivery to the distal nephron combines with increased mineralocorticoid activity at this site.
Three important actions of mineralocorticoids enhance hydrogen ion secretion by the distal renal tubule:
●Direct stimulation of the secretory H-ATPase pump
●Increased number of open epithelial sodium channels (ENaC)
●Increased activity of Na-K-ATPase
These actions combine to enhance the movement of sodium from the distal tubule lumen across the cell and into the extracellular fluid. Because sodium is reabsorbed more readily than luminal anions, its reabsorption generates an electronegative charge in the tubular lumen. The electronegative lumen reduces back-diffusion of secreted hydrogen ions from the lumen into the tubular cells and also increases distal tubule hydrogen and potassium secretion, resulting in hypokalemia and total body potassium depletion.
Have they gained alkali: from us? From themselves?
Are they losing acid?
From their stomach (acidic secretions)
From their kidneys
Raised A-a gradient (150), Acute respiratory acidosis with metabolic compensation
Can occur via three mechanisms
Excess co2 in inspired gas: laparoscopic surgery, rebreathing in anaesthetics
Increased production: malignant hyperthermia – only if ventilation otherwise impaired
Chronic respiratory alkalosis with metabolic compensation – normal in late pregnancy
Central causes: via resp centre – head injury, stroke, anxiety, drugs (antiepileptics, salicylate, propanalol, SSRI, opiate, benoz), endogenous compound (progresterone in pregnancy, cytokines in sepsis, toxins in chronic liver disease, thyrotoxicosis
Act on peripheral chemoreceptros: e.g. hypoxia, high altitude
Act on intra-pulmonary receptors: PE, pneumonia, asthma, pulmonary oedema
Iatrogenic: mechanical ventilation